The historical rank and industry rank for Diagnostic Medical Systems's FCF Margin % or its related term are showing as below:
XPAR:ALDMS'
s FCF Margin % Range Over the Past 10 Years
Min: -26.86 Med: -11.51 Max: 0.07
Current: 0.07
During the past 13 years, the highest FCF Margin % of Diagnostic Medical Systems was 0.07%. The lowest was -26.86%. And the median was -11.51%.
XPAR:ALDMS's FCF Margin % is ranked better than 50.55% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs XPAR:ALDMS: 0.07
Diagnostic Medical Systems FCF Margin % Related Terms
Diagnostic Medical Systems FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALDMS vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Diagnostic Medical Systems's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (XPAR:ALDMS) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Diagnostic Medical Systems and its competitors. According to the industry distribution chart, Diagnostic Medical Systems ranks #403 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 49.4%.
Is Diagnostic Medical Systems' FCF Margin % too high?
Diagnostic Medical Systems' current FCF Margin % is 0.00%. Based on the distribution chart, Diagnostic Medical Systems ranks #403 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Diagnostic Medical Systems has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #403 out of 815 companies for FCF Margin %. This puts Diagnostic Medical Systems in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Diagnostic Medical Systems and its competitors. Diagnostic Medical Systems's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.25 — trading 9.6% above its estimated fair value. The current FCF Margin % is 0.00%. Diagnostic Medical Systems' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.25 is trading 9.6% above its estimated GF Value™ of €1.14.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for XPAR:ALDMS:
FCF Margin %: 0.00%
GF Value™: €1.14 vs. price of €1.25 (9.6% above fair value)
No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
68GF Score
Get the complete analysis for XPAR:ALDMS
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALDMS has been successfully added to your 
